Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christos E Kyriakopoulos

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Cancer Journal (Sudbury, Mass.)|October 18, 2016
Chemohormonal Therapy for Hormone-Sensitive Prostate Cancer: A ReviewChristos E Kyriakopoulos, Glenn Liu
Annals of Translational Medicine|January 5, 2018
Surrogate end points in early prostate cancer clinical states: ready for implementation?Christos E Kyriakopoulos, Emmanuel S Antonarakis
The Urologic Clinics of North America|November 7, 2017
Newly Diagnosed Metastatic Prostate Cancer: Has the Paradigm Changed?Shivashankar Damodaran, Christos E Kyriakopoulos, David F Jarrard
Advances in Radiation Oncology|July 23, 2025
Advanced Image Analysis to Select Patients for Prostate Specific Membrane Antigen Radioligand Therapy and Assess Treatment ResponseJohn M Floberg, Christos E Kyriakopoulos, Steve Y Cho
Cases Journal|October 16, 2009
Post-traumatic splenic cysts treated with laparoscopy: two case reportsDimitrios V Avgerinos, Christos E Kyriakopoulos, Sophia Konstantinopoulou, et al.
Urology Case Reports|June 7, 2021
A case of metastatic renal cell carcinoma with concomitant Castleman's disease treated with immunotherapyTaja Lozar, Matthew J Brunner, Sujal I Shah, et al.
Clinical Medicine Insights. Oncology|March 29, 2014
Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel-an Indirect ComparisonPui S Tan, Benjamin Haaland, Alberto J Montero, et al.
Frontiers in Oncology|May 11, 2023
PARP inhibitors in metastatic prostate cancerAmy K Taylor, David Kosoff, Hamid Emamekhoo, et al.
Anticancer Research|March 6, 2020
Polycystic Liver Disease in a Patient With Metastatic Renal Cell Carcinoma: A Case ReportLucas Zarling, Hamid Emamekhoo, Gauri Bhutani, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Myeloid-derived suppressor cells in cancer patients: a clinical perspectiveAlberto J Montero, Claudia Marcela Diaz-Montero, Christos E Kyriakopoulos, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Cancer Journal (Sudbury, Mass.)|October 18, 2016
Chemohormonal Therapy for Hormone-Sensitive Prostate Cancer: A ReviewChristos E Kyriakopoulos, Glenn Liu
Annals of Translational Medicine|January 5, 2018
Surrogate end points in early prostate cancer clinical states: ready for implementation?Christos E Kyriakopoulos, Emmanuel S Antonarakis
The Urologic Clinics of North America|November 7, 2017
Newly Diagnosed Metastatic Prostate Cancer: Has the Paradigm Changed?Shivashankar Damodaran, Christos E Kyriakopoulos, David F Jarrard
Advances in Radiation Oncology|July 23, 2025
Advanced Image Analysis to Select Patients for Prostate Specific Membrane Antigen Radioligand Therapy and Assess Treatment ResponseJohn M Floberg, Christos E Kyriakopoulos, Steve Y Cho
Cases Journal|October 16, 2009
Post-traumatic splenic cysts treated with laparoscopy: two case reportsDimitrios V Avgerinos, Christos E Kyriakopoulos, Sophia Konstantinopoulou, et al.
Urology Case Reports|June 7, 2021
A case of metastatic renal cell carcinoma with concomitant Castleman's disease treated with immunotherapyTaja Lozar, Matthew J Brunner, Sujal I Shah, et al.
Clinical Medicine Insights. Oncology|March 29, 2014
Hormonal Therapeutics Enzalutamide and Abiraterone Acetate in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC) Post-docetaxel-an Indirect ComparisonPui S Tan, Benjamin Haaland, Alberto J Montero, et al.
Frontiers in Oncology|May 11, 2023
PARP inhibitors in metastatic prostate cancerAmy K Taylor, David Kosoff, Hamid Emamekhoo, et al.
Anticancer Research|March 6, 2020
Polycystic Liver Disease in a Patient With Metastatic Renal Cell Carcinoma: A Case ReportLucas Zarling, Hamid Emamekhoo, Gauri Bhutani, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 7, 2012
Myeloid-derived suppressor cells in cancer patients: a clinical perspectiveAlberto J Montero, Claudia Marcela Diaz-Montero, Christos E Kyriakopoulos, et al.
Pageof 5